VIM and cancer: As EMT of cancer cells induces the over-expression of vimentin and translocation of vimentin to the cell surface (Satelli & Li, 2011), Satelli et al tried to raise an antibody against cell surface vimentin (CSV) to capture the EMT type of CTCs (Satelli et al., 2014).